Consonance Capital Management LP Buys Surrozen Inc, Silence Therapeutics PLC, Compass Therapeutics Inc, Sells Tandem Diabetes Care Inc, SpringWorks Therapeutics Inc, United Therapeutics Corp

Author's Avatar
Feb 16, 2022
Article's Main Image
New York, NY, based Investment company Consonance Capital Management LP (Current Portfolio) buys Surrozen Inc, Silence Therapeutics PLC, Compass Therapeutics Inc, sells Tandem Diabetes Care Inc, SpringWorks Therapeutics Inc, United Therapeutics Corp, Globus Medical Inc, Olink Holding AB during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Consonance Capital Management LP. As of 2021Q4, Consonance Capital Management LP owns 15 stocks with a total value of $153 million. These are the details of the buys and sells.

For the details of Consonance Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/consonance+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Consonance Capital Management LP
  1. Tandem Diabetes Care Inc (TNDM) - 300,664 shares, 29.52% of the total portfolio. Shares reduced by 38.3%
  2. Globus Medical Inc (GMED) - 373,254 shares, 17.58% of the total portfolio. Shares reduced by 36.64%
  3. Surrozen Inc (SRZN) - 3,497,500 shares, 14.58% of the total portfolio. Shares added by 249.75%
  4. Silence Therapeutics PLC (SLN) - 758,253 shares, 11.82% of the total portfolio. Shares added by 324.11%
  5. United Therapeutics Corp (UTHR) - 59,838 shares, 8.43% of the total portfolio. Shares reduced by 62.09%
New Purchase: Compass Therapeutics Inc (CMPX)

Consonance Capital Management LP initiated holding in Compass Therapeutics Inc. The purchase prices were between $2.88 and $4.08, with an estimated average price of $3.56. The stock is now traded at around $2.369300. The impact to a portfolio due to this purchase was 7.28%. The holding were 3,500,000 shares as of 2021-12-31.

Added: Surrozen Inc (SRZN)

Consonance Capital Management LP added to a holding in Surrozen Inc by 249.75%. The purchase prices were between $6 and $9.92, with an estimated average price of $7.59. The stock is now traded at around $2.959800. The impact to a portfolio due to this purchase was 10.41%. The holding were 3,497,500 shares as of 2021-12-31.

Added: Silence Therapeutics PLC (SLN)

Consonance Capital Management LP added to a holding in Silence Therapeutics PLC by 324.11%. The purchase prices were between $20.61 and $25.71, with an estimated average price of $22.89. The stock is now traded at around $21.910000. The impact to a portfolio due to this purchase was 9.03%. The holding were 758,253 shares as of 2021-12-31.

Sold Out: SpringWorks Therapeutics Inc (SWTX)

Consonance Capital Management LP sold out a holding in SpringWorks Therapeutics Inc. The sale prices were between $53.3 and $75.84, with an estimated average price of $66.37.

Sold Out: Olink Holding AB (OLK)

Consonance Capital Management LP sold out a holding in Olink Holding AB. The sale prices were between $18 and $34.82, with an estimated average price of $24.54.

Sold Out: CASI Pharmaceuticals Inc (CASI)

Consonance Capital Management LP sold out a holding in CASI Pharmaceuticals Inc. The sale prices were between $0.77 and $1.22, with an estimated average price of $0.99.



Here is the complete portfolio of Consonance Capital Management LP. Also check out:

1. Consonance Capital Management LP's Undervalued Stocks
2. Consonance Capital Management LP's Top Growth Companies, and
3. Consonance Capital Management LP's High Yield stocks
4. Stocks that Consonance Capital Management LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles